Close

Pre-Open 09/04: (MIK) (COUP) (BOX) Higher (SUP) (SB) (AEO) Lower (more...) Sep 4, 2019 09:20AM
Aerie Pharmaceuticals to Present at the RBC Capital Markets 2017 Global Healthcare Conference Feb 15, 2017 07:30AM
RBC Affirms Aerie Pharma (AERI) at 'Outperform'; Positive on Data from Another Rho Kinase Inhibitor Oct 18, 2016 07:59AM
Aerie Pharma (AERI) Updates on Outstanding Shares, Cash Balance Sep 22, 2016 06:11AM
RBC Lifts PT on Aerie Pharma (AERI) to $55 Following Roclatan Phase 3 Results Sep 15, 2016 07:14AM


Jul 12, 2016 07:21AM RBC Sees Big Upside in Aerie Pharma (AERI) Ahead of Roclatan Phase 3 Data in September
Mar 3, 2016 02:18PM RBC Capital Comments Following Weakness in Shares of Aerie Pharma (AERI)
Feb 16, 2016 07:30AM Aerie Pharmaceuticals to Present at the RBC Capital Markets 2016 Healthcare Conference
Sep 17, 2015 09:00AM RBC Capital Boosts PT on Aeri Pharma (AERI) to $44 Following Rhopressa Phase 3 Data
Jun 16, 2015 07:28AM Aerie Pharma (AERI) Price Target Raised to $31 at RBC Capital
Apr 24, 2015 11:25AM Aerie Pharma (AERI) Price Target Lowered to $27 at RBC
Jan 29, 2015 11:27AM Aerie Pharma (AERI) Weakness Seen as Buying Opportunity at RBC
Jul 3, 2014 10:42AM Notable Analyst Rating Changes 07/03: (CREE) (ATHL) (TS) Upgraded; (RMD) (RGDO) ((NFX) Downgraded
Nov 19, 2013 07:10AM RBC Capital Starts Aerie Pharma (AERI) at Outperform
Oct 25, 2013 11:06AM Aerie Pharmaceuticals (AERI) IPO Opens Modestly Higher
Oct 15, 2013 09:30AM aerie pharmaceuticals (AERI) Sees IPO Price of $12 - $14/Share
Sep 17, 2013 05:21PM aerie pharmaceuticals (AERI) Files $57.5M IPO